The value of circulating methylated septin 9 in the diagnosis and prognostic assessment of gastric cancer
mSEPT9 shows potential in GC diagnosis and prognosis prediction, and its combination with conventional biomarkers may improve the accuracy of GC diagnosis and prognosis assessment.
Authors
- Qinghai Lin
- Xiaohe Hao
- Yongkang Wu (ORCID: https://orcid.org/0000-0002-7352-3465)
- Xinkai Mo (ORCID: https://orcid.org/0000-0002-4803-6024)
- J. Ni
- Xiangguo Yu
- Heng Liu (ORCID: https://orcid.org/0009-0005-2882-6474)
Institutions
- Shandong University (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1007/s12672-025-03702-w
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- China Scholarship Council
- Natural Science Foundation of Shandong Province